UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

Evidence-Based Guidelines for Determination of Sample Size and Interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30

Journal of clinical oncology, 2011-01, Vol.29 (1), p.89-96

2011

Link zum Volltext

Verfügbarkeit prüfen

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

The Lancet (British edition), 2010-12, Vol.376 (9757), p.1989-1999

2010

Link zum Volltext

Verfügbarkeit prüfen

The feasibility and acceptability of a primary school-based programme targeting diet and physical activity: the PhunkyFoods Programme

Pilot and feasibility studies, 2019-12, Vol.5 (1), p.152-152, Article 152

2019

Link zum Volltext

Verfügbarkeit prüfen

Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials

BMC cancer, 2021-10, Vol.21 (1), p.1-1083, Article 1083

2021

Link zum Volltext

Verfügbarkeit prüfen

How scoring limits the usability of minimal important differences (MIDs) as responder definition (RD): an exemplary demonstration using EORTC QLQ-C30 subscales

Quality of life research, 2023-05, Vol.32 (5), p.1247-1253

2023

Link zum Volltext

Verfügbarkeit prüfen

What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?

Journal of patient-reported outcomes, 2020-08, Vol.4 (1), p.68-68, Article 68

2020

Link zum Volltext

Verfügbarkeit prüfen

Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m2 vs. twice-weekly 27 mg/m2 carfilzomib (randomized A.R.R.O.W. study)

Leukemia, 2019-12, Vol.33 (12), p.2934-2946

2019

Link zum Volltext

Verfügbarkeit prüfen

A Differential Item Functioning Analysis of the EQ-5D in Cancer

Value in health, 2016-12, Vol.19 (8), p.1063-1067

2016

Link zum Volltext

Verfügbarkeit prüfen

The impact of COVID-19 on PRO development, collection and implementation: views of UK and Ireland professionals

Journal of patient-reported outcomes, 2023-11, Vol.7 (1), p.121-121, Article 121

2023

Link zum Volltext

Verfügbarkeit prüfen

Youth social behaviour and network therapy (Y-SBNT): adaptation of a family and social network intervention for young people who misuse alcohol and drugs - a randomised controlled feasibility trial

Health technology assessment (Winchester, England), 2017-03, Vol.21 (15), p.1-260

2017

Link zum Volltext

Verfügbarkeit prüfen

Sample size calculations for pilot randomized trials: a confidence interval approach

Journal of clinical epidemiology, 2013-02, Vol.66 (2), p.197-201

2013

Link zum Volltext

Verfügbarkeit prüfen

Painful leg ulceration: a prospective, longitudinal cohort study

Wound repair and regeneration, 2007-03, Vol.15 (2), p.186-191

2007

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal health‐related quality of life in first‐line treated patients with chronic lymphocytic leukemia: Results from the Connect® CLL Registry

EJHaem, 2020-07, Vol.1 (1), p.188-198

2020

Link zum Volltext

Verfügbarkeit prüfen

How strong should my anchor be for estimating group and individual level meaningful change? A simulation study assessing anchor correlation strength and the impact of sample size, distribution of change scores and methodology on establishing a true meaningful change threshold

Quality of life research, 2023-05, Vol.32 (5), p.1255-1264

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors in Renal Cell Carcinoma: Association of Preoperative Sodium Concentration with Survival

Clinical cancer research, 2008-03, Vol.14 (6), p.1775-1781

2008

Link zum Volltext

Verfügbarkeit prüfen

What is important to adults after lower limb reconstruction surgery: a conceptual framework

Quality of life research, 2023-06, Vol.32 (6), p.1671-1682

2023

Link zum Volltext

Verfügbarkeit prüfen

Correction: How strong should my anchor be for estimating group and individual level meaningful change? A simulation study assessing anchor correlation strength and the impact of sample size, distribution of change scores and methodology on establishing a true meaningful change threshold

Quality of life research, 2023-05, Vol.32 (5), p.1265-1265

2023

Link zum Volltext

Verfügbarkeit prüfen

Can patient involvement improve patient safety? A cluster randomised control trial of the Patient Reporting and Action for a Safe Environment (PRASE) intervention

BMJ quality & safety, 2017-08, Vol.26 (8), p.622

2017

Link zum Volltext

Verfügbarkeit prüfen

Validity of a single-item indicator of treatment side effect bother in a diverse sample of cancer patients

Supportive care in cancer, 2022-04, Vol.30 (4), p.3613-3623

2022

Link zum Volltext

Verfügbarkeit prüfen

Ongoing validation of health-related quality of life instruments

Trials, 2015-11, Vol.16 (S2), p.O8-O8, Article O8

2015

Link zum Volltext

Verfügbarkeit prüfen

International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

The lancet oncology, 2020-02, Vol.21 (2), p.e83-e96

2020

Link zum Volltext

Verfügbarkeit prüfen

Can staff and patient perspectives on hospital safety predict harm-free care? An analysis of staff and patient survey data and routinely collected outcomes

BMJ quality & safety, 2015-06, Vol.24 (6), p.369-376

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(113)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evidence-Based Guidelines for Determination of Sample Size and Interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

The feasibility and acceptability of a primary school-based programme targeting diet and physical activity: the PhunkyFoods Programme

Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials

How scoring limits the usability of minimal important differences (MIDs) as responder definition (RD): an exemplary demonstration using EORTC QLQ-C30 subscales

Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial

What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?

Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m2 vs. twice-weekly 27 mg/m2 carfilzomib (randomized A.R.R.O.W. study)

A Differential Item Functioning Analysis of the EQ-5D in Cancer

The impact of COVID-19 on PRO development, collection and implementation: views of UK and Ireland professionals

Youth social behaviour and network therapy (Y-SBNT): adaptation of a family and social network intervention for young people who misuse alcohol and drugs - a randomised controlled feasibility trial

Sample size calculations for pilot randomized trials: a confidence interval approach

P1683: THE EORTC QLQ‐HL27: EORTC PROSPECTIVE INTERNATIONAL VALIDATION OF A DISEASE‐SPECIFIC QUESTIONNAIRE FOR ASSESSMENT OF HEALTH‐RELATED QUALITY OF LIFE IN PATIENTS WITH HODGKIN LYMPHOMA

Painful leg ulceration: a prospective, longitudinal cohort study

Longitudinal health‐related quality of life in first‐line treated patients with chronic lymphocytic leukemia: Results from the Connect® CLL Registry

How strong should my anchor be for estimating group and individual level meaningful change? A simulation study assessing anchor correlation strength and the impact of sample size, distribution of change scores and methodology on establishing a true meaningful change threshold

Prognostic Factors in Renal Cell Carcinoma: Association of Preoperative Sodium Concentration with Survival

What is important to adults after lower limb reconstruction surgery: a conceptual framework

Correction: How strong should my anchor be for estimating group and individual level meaningful change? A simulation study assessing anchor correlation strength and the impact of sample size, distribution of change scores and methodology on establishing a true meaningful change threshold

Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

Can patient involvement improve patient safety? A cluster randomised control trial of the Patient Reporting and Action for a Safe Environment (PRASE) intervention

Validity of a single-item indicator of treatment side effect bother in a diverse sample of cancer patients

Ongoing validation of health-related quality of life instruments

International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

Can staff and patient perspectives on hospital safety predict harm-free care? An analysis of staff and patient survey data and routinely collected outcomes

Suchergebnisse filtern